TY - JOUR
T1 - Fatal Outbreak of an Emerging Clone of Extensively Drug-Resistant Acinetobacter baumannii with Enhanced Virulence
AU - Jones, Crystal L.
AU - Clancy, Megan
AU - Honnold, Cary
AU - Singh, Shweta
AU - Snesrud, Erik
AU - Onmus-Leone, Fatma
AU - McGann, Patrick
AU - Ong, Ana C.
AU - Kwak, Yoon
AU - Waterman, Paige
AU - Zurawski, Daniel V.
AU - Clifford, Robert J.
AU - Lesho, Emil
N1 - Publisher Copyright:
© 2015 Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.
PY - 2015/7/15
Y1 - 2015/7/15
N2 - Background. Severe Acinetobacter baumannii infections in immunocompetent patients are uncommon, and the virulence mechanisms of this organism are not fully understood. Methods. Following an outbreak of fatal A. baumannii infections in a cohort of relatively immunocompetent patients (low comorbidity and illness severity scores), isolates were investigated with comparative genomics and in animal models. Results. Two unrelated A. baumannii clades were associated with the outbreak. The clone associated with the majority of patient deaths, clade B, is evolutionarily distinct from the 3 international clonal complexes, belongs to multilocus sequence type (MLST) 10, and is most closely related to strains isolated from the Czech Republic, California, and Germany in 1994, 1997, and 2003, respectively. In 2 different murine models, clade B isolates were more virulent than comparator strains, including the highly virulent reference strain AB5075. The most virulent clade B derivative, MRSN 16897, was isolated from the patient with the lowest combined comorbidity/illness severity score. Clade B isolates possess a unique combination of putative virulence genes involved in iron metabolism, protein secretion, and glycosylation, which was leveraged to develop a rapid and specific clinical assay to detect this clade that cannot be distinguished by MLST. Conclusions. Clade B warrants continued surveillance and investigation.
AB - Background. Severe Acinetobacter baumannii infections in immunocompetent patients are uncommon, and the virulence mechanisms of this organism are not fully understood. Methods. Following an outbreak of fatal A. baumannii infections in a cohort of relatively immunocompetent patients (low comorbidity and illness severity scores), isolates were investigated with comparative genomics and in animal models. Results. Two unrelated A. baumannii clades were associated with the outbreak. The clone associated with the majority of patient deaths, clade B, is evolutionarily distinct from the 3 international clonal complexes, belongs to multilocus sequence type (MLST) 10, and is most closely related to strains isolated from the Czech Republic, California, and Germany in 1994, 1997, and 2003, respectively. In 2 different murine models, clade B isolates were more virulent than comparator strains, including the highly virulent reference strain AB5075. The most virulent clade B derivative, MRSN 16897, was isolated from the patient with the lowest combined comorbidity/illness severity score. Clade B isolates possess a unique combination of putative virulence genes involved in iron metabolism, protein secretion, and glycosylation, which was leveraged to develop a rapid and specific clinical assay to detect this clade that cannot be distinguished by MLST. Conclusions. Clade B warrants continued surveillance and investigation.
KW - Acinetobacter baumannii
KW - extensively drug resistant
KW - outbreak
KW - virulence
UR - http://www.scopus.com/inward/record.url?scp=84936772293&partnerID=8YFLogxK
U2 - 10.1093/cid/civ225
DO - 10.1093/cid/civ225
M3 - Article
C2 - 25824815
AN - SCOPUS:84936772293
SN - 1058-4838
VL - 61
SP - 145
EP - 154
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 2
ER -